IMMUCELL Trademark

Trademark Overview


On Friday, May 17, 2002, a trademark application was filed for IMMUCELL with the United States Patent and Trademark Office. The USPTO has given the IMMUCELL trademark a serial number of 76409470. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, August 15, 2022. This trademark is owned by ImmuCell Corporation. The IMMUCELL trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary preparations, namely, diagnostic kits for clinical or medical laboratory use, antibody preparations for livestock, pharmaceutical preparations for livestock for treating scours, mastitis, and infectious diseases, and pre-moistened towelettes impregnated with antimicrobial and skin conditioning material for cleaning animal teats
immucell

General Information


Serial Number76409470
Word MarkIMMUCELL
Filing DateFriday, May 17, 2002
Status800 - REGISTERED AND RENEWED
Status DateMonday, August 15, 2022
Registration Number2688577
Registration DateTuesday, February 18, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 26, 2002

Trademark Statements


Goods and ServicesVeterinary preparations, namely, diagnostic kits for clinical or medical laboratory use, antibody preparations for livestock, pharmaceutical preparations for livestock for treating scours, mastitis, and infectious diseases, and pre-moistened towelettes impregnated with antimicrobial and skin conditioning material for cleaning animal teats
Pseudo MarkIMMUNE CELL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 24, 2002
Primary Code005
First Use Anywhere DateFriday, September 30, 1983
First Use In Commerce DateFriday, September 30, 1983

Trademark Owner History


Party NameImmuCell Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPortland, ME 04103

Party NameImmuCell Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPortland, ME 04103

Party NameImmuCell Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, ME 04103

Trademark Events


Event DateEvent Description
Tuesday, August 16, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, August 15, 2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Monday, August 15, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 15, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 24, 2022TEAS SECTION 8 & 9 RECEIVED
Friday, February 18, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 4, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 4, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 28, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
Tuesday, August 28, 2012REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, August 28, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 27, 2012REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Monday, August 27, 2012PAPER RECEIVED
Tuesday, February 17, 2009CASE FILE IN TICRS
Wednesday, January 28, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 10, 2008REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, December 10, 2008PAPER RECEIVED
Tuesday, February 18, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2002PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2002NOTICE OF PUBLICATION
Tuesday, September 17, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 10, 2002EXAMINER'S AMENDMENT MAILED
Wednesday, September 4, 2002ASSIGNED TO EXAMINER
Wednesday, July 17, 2002PAPER RECEIVED